clinical trial · NCT00571727
Long-Term Treatment With rhIGF-1 in GHIS
Ipsen·phase3·completed·n = 92
Growth Hormone Insensitivity Syndromemecasermin
brief summary
The objective of this study was to evaluate the long-term safety and effectiveness of mecasermin (the study drug) in children with growth failure due to severe Primary insulin-like growth factor-1 deficiency (Primary IGFD).
started
May 20, 1991
primary completion
Dec 15, 2011
completion
Dec 15, 2011
last updated
Jul 6, 2023
official title
A Study of Long-Term Human Recombinant Insulin-Like Growth Factor-1 (rhIGF-1) in Children With Short Stature Due to Growth Hormone Insensitivity Syndrome (GHIS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol